Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: The Dana Farber Cancer Institute experience

Cancer

Volumn 97, Issue 2, 2003, Pages 412-418

  Haddad, Robert ^a   Colevas, A Dimitrios ^b   Tishler, Roy ^c   Busse, Paul ^c   Goguen, Laura ^c   Sullivan, Christopher ^c   Norris, Charles M ^c   Lake Willcutt, Bernadette ^c   Case, Mary Ann ^c   Costello, Rosemary ^c   Posner, Marshall ^c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

5 fluorouracil; Cisplatin; Docetaxel; Head and neck carcinoma; Hyperfractionated radiotherapy; Induction chemotherapy

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CISPLATIN; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR;

ADVANCED CANCER; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; HEAD AND NECK CARCINOMA; HUMAN; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MAXILLA SINUS CANCER; MOUTH CARCINOMA; MULTICENTER STUDY; NASOPHARYNX CARCINOMA; OROPHARYNX CARCINOMA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; SEPSIS; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; TISSUE NECROSIS; TREATMENT OUTCOME;

EID: 0037439588     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11063     Document Type: Article

References (20)

1. Forastiere A, Kock W, Trotti A, Sidransky D. Medical progress: head and neck cancer. N Engl J Med. 2001;345:1890-1900.
2. Domenge C, Hill C, Lefebvre J, et al. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. Br J Cancer. 2000;83:1594-1598.
3. Lefebvre J, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer Phase III trial. J Natl Cancer Inst. 1996;88:890-898.
4. Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med, 1991;324:1685-1689.
5. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced stage oropharynx carcinoma. J Natl Cancer Inst, 1999;91:2081-2086.
6. Paccagnella A, Orlando A, Marchiori C, et al. Phase III trial of initial chemotherapy in Stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst. 1994;86:265-272.
7. Dreyfuss A, Clark J, Norris C, et al. Docetaxel: an active drug for squamous cell carcinoma of the head and neck. J Clin Oncol. 1996;14:1672-1678.
8. Catimel G, Verwij J, Hanauske A. Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. Ann Oncol. 1994;5:553-537.
9. Couteau C, Leyvraz S, Oulid-Aissa D, et al. A Phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck. Br J Cancer. 1999;81:457-462.
10. Colevas A, Busse P, Norris C, et al. Induction chemotherapy with docetaxel, cisplatin, 5-fluorouracil, and leucovorin (TPFL5) for squamous cell carcinoma of the head and neck: a Phase I/II trial. J Clin Oncol. 1998;16:1331-1339.
11. Colevas A, Norris C, Tishler R, et al. A Phase II trial of TPFL (docetaxel, cisplatin, 5-fluorouracil, leucovorin) as induction for squamous cell carcinoma of the head and neck (SCCHN). J Clin Oncol. 1999;17:3503-3511.
12. Colevas A, Norris C, Tishler R, et al. A Phase I/II Study of outpatient docetaxel, cisplatin, 5-fluorouracil, and leucovorin (op-TPFL) as induction for squamous cell carcinoma of the head and neck (SCCHN). Am J Clin Oncol. 2002;25:153-159.
13. Posner M, Glisson B, Frenette G, et al. A multi-center Phase I-II trial of docetaxel, cisplatinum, and 5-fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck. J Clin Oncol. 2001;19:1096-1104.
14. Forastiere AA, Berkey B, Maor M, et al. Phase III trial to preserve the larynx: induction chemotherapy and radiotherapy versus concomitant chemoradiotherapy versus radiotherapy alone. Intergroup Trial R91-11 [abstract]. Proc Am Soc Clin Oncol. 2001;20:2a.
15. Calais G, Alfonsi M, Bardet E, et al. Radiation alone (RT) versus RT with concomitant chemotherapy (CT) in Stages III and IV oropharynx carcinoma. Final results of the 94-01 GORTEC randomized study. Proceedings of the 43rd annual ASTRO meeting, 2001. Int J Radial Oncol Biol Physics. 2001;51(Suppl 1):1-2.
16. Fu K, Pajak T, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) Phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000;48:7-16.
17. Posner M. Sequential chemotherapy for the curative treatment of squamous cell cancer of the head and neck: a new paradigm. Oncol Spectrums, 2001;2:193-202.
18. Posner M, Colevas A, Tishler R. The role of induction chemotherapy in the curative treatments of squamous cell cancer of the head and neck. Semin Oncol. 2000;27(Suppl G):13-24.
19. Vokes E, Kies M, Rosen F, et al. Induction chemotherapy followed by concomitant chemoradiotherapy for Stage IV head and neck cancer: an attempt at locoregional and systemic tumor control. Proc Am Soc Clin Oncol. 2000;19:1653.
20. Gray J, Meluch A, Greco F, et al, Induction paclitaxel/carboplatin/5FU followed by concurrent radiotherapy and weekly paclitaxel/carboplatin for patients with locally advanced head and neck cancer (HNC): a Minnie Pearl Cancer Research Network trial [abstract]. Proc Am Soc Clin Oncol. 2001;20:226a.